Axial spondyloarthritis

Gender differences in patient journey to diagnosis and disease outcomes: results from the European Map of Axial Spondyloarthritis (EMAS)

(2021) Marco Garrido-Cumbrera et al.   CLINICAL RHEUMATOLOGY

The ASAS-OMERACT core domain set for axial spondyloarthritis

(2021) V. Navarro-Compán et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Biological DMARDs and disease modification in axial spondyloarthritis: a review through the lens of causal inference

(2021) Alexandre Sepriano et al.   RMD Open

What is axial spondyloarthritis? A latent class and transition analysis in the SPACE and DESIR cohorts

(2020) Alexandre Sepriano et al.   ANNALS OF THE RHEUMATIC DISEASES

The phenotype of axial spondyloarthritis: is it dependent on HLA‐B27 status?

(2020) Laura C Coates et al.   ARTHRITIS CARE & RESEARCH

The Effect of Therapy on Radiographic Progression in Axial Spondyloarthritis: A Systematic Review and Meta‐Analysis

(2020) Paras Karmacharya et al.   Arthritis & Rheumatology

Dual neutralisation of interleukin-17A and interleukin-17F with bimekizumab in patients with active ankylosing spondylitis: results from a 48-week phase IIb, randomised, double-blind, placebo-controlled, dose-ranging study

(2020) Désirée van der Heijde et al.   ANNALS OF THE RHEUMATIC DISEASES

Effectiveness of secukinumab versus an alternative TNF inhibitor in patients with axial spondyloarthritis previously exposed to TNF inhibitors in the Swiss Clinical Quality Management cohort

(2020) Raphael Micheroli et al.   ANNALS OF THE RHEUMATIC DISEASES

Secukinumab improves signs and symptoms of non‐radiographic axial spondyloarthritis: primary results of a randomized controlled phase III study

(2020) Atul Deodhar et al.   Arthritis & Rheumatology

Sex and gender differences in axial spondyloarthritis: myths and truths

(2020) Tamara Rusman et al.   RHEUMATOLOGY

Measuring Outcomes in Axial Spondyloarthritis

(2020) Alexis Ogdie et al.   ARTHRITIS CARE & RESEARCH

The European Map of Axial Spondyloarthritis: Capturing the Patient Perspective—an Analysis of 2846 Patients Across 13 Countries

(2019) Marco Garrido-Cumbrera et al.   Current Rheumatology Reports

What constitutes the fat signal detected by MRI in the spine of patients with ankylosing spondylitis? A prospective study based on biopsies obtained during planned spinal osteotomy to correct hyperkyphosis or spinal stenosis

(2019) Xenofon Baraliakos et al.   ANNALS OF THE RHEUMATIC DISEASES

Peripheral manifestations in spondyloarthritis and their impact: an ancillary analysis of the ASAS-COMOSPA study.

(2019) Clementina López-Medina et al.   JOURNAL OF RHEUMATOLOGY

Is a positive family history of spondyloarthritis relevant for diagnosing axial spondyloarthritis once HLA-B27 status is known?

(2019) Miranda van Lunteren et al.   RHEUMATOLOGY

Performance of magnetic resonance imaging in the diagnosis of axial spondyloarthritis: a systematic literature review

(2019) Alexis Jones et al.   RHEUMATOLOGY

Low specificity but high sensitivity of inflammatory back pain criteria in rheumatology settings in Europe: confirmation of findings from a German cohort study

(2019) Manouk de Hooge et al.   ANNALS OF THE RHEUMATIC DISEASES

An Update on Diagnosis and Classification of Axial Spondyloarthritis

(2019) Victoria Navarro-Compán   Current Rheumatology Reports

The IL-23–IL-17 pathway as a therapeutic target in axial spondyloarthritis

(2019) Joachim Sieper et al.   Nature Reviews Rheumatology

The effect of tumour necrosis factor inhibitors on radiographic progression in axial spondyloarthritis: a systematic literature review

(2019) Nadine Boers et al.   RHEUMATOLOGY

2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis

(2019) Michael M. Ward et al.   Arthritis & Rheumatology

Development of ASAS quality standards to improve the quality of health and care services for patients with axial spondyloarthritis

(2019) Uta Kiltz et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and COAST-W)

(2019) Maxime Dougados et al.   ANNALS OF THE RHEUMATIC DISEASES

Unmet need in rheumatology: reports from the Targeted Therapies meeting 2019

(2019) Kevin L Winthrop et al.   ANNALS OF THE RHEUMATIC DISEASES

The role of imaging in the diagnosis and management of axial spondyloarthritis

(2019) Walter P. Maksymowych   Nature Reviews Rheumatology

Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2/3 trial

(2019) Désirée van der Heijde et al.   LANCET

Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial

(2019) Atul Deodhar et al.   LANCET

Ankylosing Spondylitis Disease Activity Score (ASDAS): 2018 update of the nomenclature for disease activity states

(2018) Pedro M Machado et al.   ANNALS OF THE RHEUMATIC DISEASES

Overdiagnosis and overtreatment in rheumatology: a little caution is in order

(2018) Robert B M Landewé   ANNALS OF THE RHEUMATIC DISEASES

Frequency of Impaired Spinal Mobility in Patients with Chronic Back Pain Compared to Patients with Early Axial Spondyloarthritis

(2018) Camilla Fongen et al.   JOURNAL OF RHEUMATOLOGY

Efficacy and safety of continuing versus withdrawing adalimumab therapy in maintaining remission in patients with non-radiographic axial spondyloarthritis (ABILITY-3): a multicentre, randomised, double-blind study

(2018) Robert Landewé et al.   LANCET

Magnetic Resonance Imaging of the Sacroiliac Joints Indicating Sacroiliitis According to the Assessment of SpondyloArthritis international Society Definition in Healthy Individuals, Runners, and Women With Postpartum Back Pain

(2018) Janneke de Winter et al.   Arthritis & Rheumatology

Clinical Evolution in Patients With New-Onset Inflammatory Back Pain

(2018) Runsheng Wang et al.   Arthritis & Rheumatology

Effects of the IL-23–IL-17 pathway on bone in spondyloarthritis

(2018) Ellen M. Gravallese et al.   Nature Reviews Rheumatology

Three Multicenter, Randomized, Double-Blind, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial Spondyloarthritis

(2018) Atul Deodhar et al.   Arthritis & Rheumatology

Is it useful to repeat MRI of the sacroiliac joints after three months or one year in the diagnostic process of patients with chronic back pain suspected of axial spondyloarthritis?

(2018) P A Bakker et al.   Arthritis & Rheumatology

Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial

(2018) Désirée van der Heijde et al.   LANCET

Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trial

(2018) Désirée van der Heijde et al.   LANCET

Is active sacroiliitis on MRI associated with radiographic damage in axial spondyloarthritis? Real-life data from the ASAS and DESIR cohorts

(2018) Alexandre Sepriano et al.   RHEUMATOLOGY

The Early Phases of Ankylosing Spondylitis: Emerging Insights From Clinical and Basic Science

(2018) Abdulla Watad et al.   Frontiers in Immunology

Axial spondyloarthritis

(2017) Joachim Sieper et al.   LANCET

Enthesitis: from pathophysiology to treatment

(2017) Georg Schett et al.   Nature Reviews Rheumatology

Mechanism of New Bone Formation in Axial Spondyloarthritis

(2017) Denis Poddubnyy et al.   Current Rheumatology Reports

An ankylosing spondylitis-associated genetic variant in theIL23R-IL12RB2intergenic region modulates enhancer activity and is associated with increased Th1-cell differentiation

(2016) Amity R Roberts et al.   ANNALS OF THE RHEUMATIC DISEASES

Why CAPS criteria are not diagnostic criteria?

(2016) Robert BM Landewé et al.   ANNALS OF THE RHEUMATIC DISEASES

The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation

(2016) Carina Götestam Skorpen et al.   ANNALS OF THE RHEUMATIC DISEASES

High disease activity according to the Ankylosing Spondylitis Disease Activity Score is associated with accelerated radiographic spinal progression in patients with early axial spondyloarthritis: results from the GErman SPondyloarthritis Inception Cohort

(2016) Denis Poddubnyy et al.   ANNALS OF THE RHEUMATIC DISEASES

Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: update by the ASAS MRI working group

(2016) Robert G W Lambert et al.   ANNALS OF THE RHEUMATIC DISEASES

Understanding How the Diagnostic Delay of Spondyloarthritis Differs Between Women and Men: A Systematic Review and Metaanalysis

(2016) Vega Jovaní et al.   JOURNAL OF RHEUMATOLOGY

Nonsteroidal Antiinflammatory Drugs for Axial Spondyloarthritis: A Cochrane Review

(2016) F. P. B. Kroon et al.   JOURNAL OF RHEUMATOLOGY

Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci

(2016) David Ellinghaus et al.   NATURE GENETICS

Anti-TNF discontinuation and tapering strategies in patients with axial spondyloarthritis: a systematic literature review

(2016) Victoria Navarro-Compán et al.   RHEUMATOLOGY

Global Prevalence of Spondyloarthritis: A Systematic Review and Meta-Regression Analysis

(2016) Carmen Stolwijk et al.   ARTHRITIS CARE & RESEARCH

Patients with chronic back pain of short duration from the SPACE cohort: which MRI structural lesions in the sacroiliac joints and inflammatory and structural lesions in the spine are most specific for axial spondyloarthritis?

(2015) Manouk de Hooge et al.   ANNALS OF THE RHEUMATIC DISEASES

MRI vertebral corner inflammation followed by fat deposition is the strongest contributor to the development of new bone at the same vertebral corner: a multilevel longitudinal analysis in patients with ankylosing spondylitis

(2015) Pedro M Machado et al.   ANNALS OF THE RHEUMATIC DISEASES

Effect of continuous versus on-demand treatment of ankylosing spondylitis with diclofenac over 2 years on radiographic progression of the spine: results from a randomised multicentre trial (ENRADAS)

(2015) Joachim Sieper et al.   ANNALS OF THE RHEUMATIC DISEASES

Development of an ASAS-endorsed recommendation for the early referral of patients with a suspicion of axial spondyloarthritis

(2015) Denis Poddubnyy et al.   ANNALS OF THE RHEUMATIC DISEASES

EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice

(2015) P Mandl et al.   ANNALS OF THE RHEUMATIC DISEASES

The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease

(2015) Marcus Harbord et al.   Journal of Crohns & Colitis

Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis

(2015) Dominique Baeten et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety of Etoricoxib, Celecoxib, and Nonselective Nonsteroidal Antiinflammatory Drugs in Ankylosing Spondylitis and Other Spondyloarthritis Patients: A Swedish National Population-Based Cohort Study

(2015) L. E. Kristensen et al.   ARTHRITIS CARE & RESEARCH

Clinical Tools to Assess and Monitor Spondyloarthritis

(2015) Robert Landewé et al.   Current Rheumatology Reports

A Randomized, Double-Blind, Placebo-Controlled, Sixteen-Week Study of Subcutaneous Golimumab in Patients With Active Nonradiographic Axial Spondyloarthritis

(2015) J. Sieper et al.   Arthritis & Rheumatology

Brief Report: Calculating the Ankylosing Spondylitis Disease Activity Score If the Conventional C-Reactive Protein Level Is Below the Limit of Detection or If High-Sensitivity C-Reactive Protein Is Used: An Analysis in the DESIR Cohort

(2015) Pedro Machado et al.   Arthritis & Rheumatology

Reference intervals of spinal mobility measures in normal individuals: the mobility study

(2014) Sofia Ramiro et al.   ANNALS OF THE RHEUMATIC DISEASES

Sarilumab for the treatment of ankylosing spondylitis: results of a Phase II, randomised, double-blind, placebo-controlled study (ALIGN)

(2014) Joachim Sieper et al.   ANNALS OF THE RHEUMATIC DISEASES

Development of a health index in patients with ankylosing spondylitis (ASAS HI): final result of a global initiative based on the ICF guided by ASAS

(2014) U Kiltz et al.   ANNALS OF THE RHEUMATIC DISEASES

Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort

(2014) Sofia Ramiro et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy of TNFα blockers in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a meta-analysis

(2014) Johanna Callhoff et al.   ANNALS OF THE RHEUMATIC DISEASES

How well are the ASAS/OMERACT Core Outcome Sets for Ankylosing Spondylitis implemented in randomized clinical trials? A systematic literature review

(2014) Wilson Bautista-Molano et al.   CLINICAL RHEUMATOLOGY

Agreement Between Clinical Practice and Trained Central Reading in Reading of Sacroiliac Joints on Plain Pelvic Radiographs: Results From the DESIR Cohort

(2014) Rosaline van den Berg et al.   Arthritis & Rheumatology

The Concept of Axial Spondyloarthritis: Joint Statement of the Spondyloarthritis Research and Treatment Network and the Assessment of SpondyloArthritis international Society in Response to the US Food and Drug Administration's Comments and Concerns

(2014) Atul Deodhar et al.   Arthritis & Rheumatology

Which spinal lesions are associated with new bone formation in patients with ankylosing spondylitis treated with anti-TNF agents? A long-term observational study using MRI and conventional radiography

(2013) X Baraliakos et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study

(2013) R Landewé et al.   ANNALS OF THE RHEUMATIC DISEASES

Assessment of short-term symptomatic efficacy of tocilizumab in ankylosing spondylitis: results of randomised, placebo-controlled trials

(2013) Joachim Sieper et al.   ANNALS OF THE RHEUMATIC DISEASES

Prevalence of spondyloarthritis in reference to HLA-B27 in the French population: results of the GAZEL cohort

(2013) Félicie Costantino et al.   ANNALS OF THE RHEUMATIC DISEASES

Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: a systematic review and meta-analysis

(2013) Carmen Stolwijk et al.   ANNALS OF THE RHEUMATIC DISEASES

Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci

(2013) Adrian Cortes et al.   NATURE GENETICS

One-year follow-up of ankylosing spondylitis patients responding to rituximab treatment and re-treated in case of a flare

(2012) In-Ho Song et al.   ANNALS OF THE RHEUMATIC DISEASES

Similar response rates in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis after 1 year of treatment with etanercept: results from the ESTHER trial

(2012) In-Ho Song et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1)

(2012) Joachim Sieper et al.   ANNALS OF THE RHEUMATIC DISEASES

Microscopic gut inflammation in axial spondyloarthritis: a multiparametric predictive model

(2012) Liesbet Van Praet et al.   ANNALS OF THE RHEUMATIC DISEASES

Continuous NSAID use reverts the effects of inflammation on radiographic progression in patients with ankylosing spondylitis

(2012) Féline Kroon et al.   ANNALS OF THE RHEUMATIC DISEASES

ASAS modification of the Berlin algorithm for diagnosing axial spondyloarthritis: results from the SPondyloArthritis Caught Early (SPACE)-cohort and from the Assessment of SpondyloArthritis international Society (ASAS)-cohort

(2012) Rosaline van den Berg et al.   ANNALS OF THE RHEUMATIC DISEASES

Review: Nonradiographic axial spondyloarthritis: New definition of an old disease?

(2012) Joachim Sieper et al.   ARTHRITIS AND RHEUMATISM

Assessment of SpondyloArthritis International Society criteria for axial spondyloarthritis in chronic back pain patients with a high prevalence of HLA-B27

(2012) Gunnstein Bakland et al.   ARTHRITIS CARE & RESEARCH

A stratified model for health outcomes in ankylosing spondylitis

(2011) P. Machado et al.   ANNALS OF THE RHEUMATIC DISEASES

MRI inflammation at the vertebral unit only marginally predicts new syndesmophyte formation: a multilevel analysis in patients with ankylosing spondylitis

(2011) Désirée van der Heijde et al.   ANNALS OF THE RHEUMATIC DISEASES

Rates and predictors of radiographic sacroiliitis progression over 2 years in patients with axial spondyloarthritis

(2011) D. Poddubnyy et al.   ANNALS OF THE RHEUMATIC DISEASES

Treatment of active ankylosing spondylitis with abatacept: an open-label, 24-week pilot study

(2011) I.-H. Song et al.   ANNALS OF THE RHEUMATIC DISEASES

Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility

(2011) David M Evans et al.   NATURE GENETICS

The diagnostic utility of magnetic resonance imaging in spondylarthritis: An international multicenter evaluation of one hundred eighty-seven subjects

(2010) Ulrich Weber et al.   ARTHRITIS AND RHEUMATISM

The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection

(2009) M Rudwaleit et al.   ANNALS OF THE RHEUMATIC DISEASES

New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS)

(2009) J Sieper et al.   ANNALS OF THE RHEUMATIC DISEASES

The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal

(2009) M Rudwaleit et al.   ANNALS OF THE RHEUMATIC DISEASES

Inflammatory lesions of the spine on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis: Evidence of a relationship between inflammation and new bone formation

(2009) Walter P. Maksymowych et al.   ARTHRITIS AND RHEUMATISM

Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis

(2008) C Lukas et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy and safety of golimumab in patients with ankylosing spondylitis: Results of a randomized, double-blind, placebo-controlled, phase III trial

(2008) Robert D. Inman et al.   ARTHRITIS AND RHEUMATISM